Invictus MD Strategies Corp. (IVITF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Invictus MD Strategies Corp. (IVITF) trades at $0.00 with AI Score 52/100 (Grade B). Invictus MD Strategies Corp. operates in the Canadian cannabis industry, focusing on the production and sale of medical cannabis and related products. Market cap: $4.45M, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for IVITF: IVITF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IVITF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
IVITF: the 6 perspectives are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Invictus MD Strategies Corp. (IVITF) Healthcare & Pipeline Overview
Invictus MD Strategies Corp. is a Canadian cannabis company involved in the production and sale of medical cannabis, fertilizers, and hydroponics supplies. Operating in a competitive market, Invictus also invests in synergistic cannabis-related businesses and operates medical clinics in Alberta, facing challenges common to the OTC market.
What Is the Investment Thesis for IVITF?
Invictus MD Strategies Corp. presents a speculative investment opportunity within the Canadian cannabis sector. The company's involvement in both cannabis production and related products like fertilizers offers diversification. However, the company's negative profit margin of -761.0% and gross margin of -81.0% raise concerns about its financial sustainability. Growth catalysts include potential expansion of its medical clinic network and increased demand for cannabis products. The company's OTC listing introduces additional risks related to liquidity and regulatory oversight. Investors should carefully consider the company's financial performance, competitive landscape, and the risks associated with OTC-listed companies before investing. The absence of a dividend further reduces the attractiveness for income-seeking investors.
Based on FMP financials and quantitative analysis
IVITF Key Highlights
- Market capitalization of $4.45M indicates a micro-cap company with limited financial resources.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Profit Margin of -761.0% signals significant losses and operational inefficiencies.
- Gross Margin of -81.0% indicates that the cost of goods sold exceeds revenue, posing a major challenge.
- Beta of 0.70 suggests the stock is less volatile than the overall market.
Who Are IVITF's Competitors?
IVITF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IVITF's Key Strengths?
- Diversified operations across cannabis production, retail, and healthcare.
- Established presence in the Canadian cannabis market.
- Synergistic business model integrating various aspects of the cannabis industry.
- Operation of medical clinics providing direct access to patients.
What Are IVITF's Weaknesses?
- Negative profit margin and gross margin indicating financial challenges.
- Limited financial resources compared to larger competitors.
- Reliance on the Canadian cannabis market, exposing it to regulatory risks.
- OTC listing introducing additional risks related to liquidity and regulatory oversight.
What Could Drive IVITF Stock Higher?
- Expansion of medical cannabis production capacity to meet increasing demand.
- Development and launch of new cannabis-based products, such as edibles and concentrates.
- Expansion of the company's network of medical clinics in Alberta and other provinces.
- Regulatory changes in Canada that could further liberalize the cannabis market.
- Strategic partnerships or acquisitions that could expand the company's reach and market share.
What Are the Key Risks for IVITF?
- Financial-distress signal — its Altman Z-Score of -1.62 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-31.9%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger, more established companies in the cannabis industry.
- Evolving regulatory landscape of the cannabis industry, creating uncertainty and compliance costs.
- Fluctuations in cannabis prices affecting revenue and profitability.
- Limited access to capital due to the company's micro-cap status and OTC listing.
- Negative profit and gross margins indicating financial instability.
What Are the Growth Opportunities for IVITF?
- Expansion of Medical Clinic Network: Invictus MD Strategies Corp. can expand its network of medical clinics in Alberta and other provinces to increase access to medical cannabis for patients. The growing acceptance of medical cannabis and increasing patient demand create opportunities for clinic expansion. This expansion could involve opening new clinics, acquiring existing clinics, or partnering with healthcare providers. The market for medical cannabis clinics is expected to grow as more patients seek cannabis-based treatments for various medical conditions. Timeline: Ongoing.
- Increased Production Capacity: Invictus MD Strategies Corp. can increase its cannabis production capacity to meet growing demand. This could involve expanding existing cultivation facilities or building new facilities. Increased production capacity would allow the company to increase its sales volume and market share. The Canadian cannabis market is expected to continue to grow as legalization expands and consumer demand increases. Timeline: Ongoing.
- Product Diversification: Invictus MD Strategies Corp. can diversify its product offerings to include a wider range of cannabis products, such as edibles, concentrates, and topicals. This would allow the company to appeal to a broader range of consumers and increase its revenue streams. The market for cannabis products is becoming increasingly diverse, with consumers seeking a variety of consumption methods and product types. Timeline: Ongoing.
- Strategic Partnerships: Invictus MD Strategies Corp. can form strategic partnerships with other companies in the cannabis industry to expand its reach and access new markets. These partnerships could involve joint ventures, licensing agreements, or distribution agreements. Strategic partnerships can provide access to new technologies, expertise, and distribution channels. Timeline: Ongoing.
- International Expansion: Invictus MD Strategies Corp. can explore opportunities to expand its operations internationally, particularly in countries where cannabis is legal or becoming legal. International expansion would allow the company to tap into new markets and diversify its revenue streams. The global cannabis market is expected to grow significantly in the coming years as more countries legalize cannabis for medical or recreational use. Timeline: Potential.
What Opportunities Does IVITF Have?
- Expansion of medical clinic network to increase patient access.
- Increased production capacity to meet growing demand.
- Product diversification to appeal to a broader range of consumers.
- Strategic partnerships to expand reach and access new markets.
What Threats Does IVITF Face?
- Intense competition from larger, more established companies.
- Evolving regulatory landscape of the cannabis industry.
- Fluctuations in cannabis prices affecting revenue and profitability.
- Potential changes in consumer preferences and demand.
What Are IVITF's Competitive Advantages?
- Synergistic business model integrating cannabis production, retail, and healthcare.
- Established presence in the Canadian cannabis market.
- Operation of medical clinics providing direct access to patients.
- Investment in and development of cannabis-related businesses.
What Does IVITF Do?
Invictus MD Strategies Corp., incorporated in 2014 and headquartered in Vancouver, Canada, is a cannabis company focused on investing in, acquiring, and developing synergistic businesses within the Canadian cannabis industry. The company operates through two primary segments: the Sale of Cannabis and Fertilizers. Its operations include the production and sale of medical cannabis, catering to the growing demand for cannabis-based medicinal products. Additionally, Invictus MD Strategies Corp. produces and sells plant fertilizers, nutrients, and other supplies essential for hydroponics, targeting both commercial and individual growers. The company also operates medical clinics in Alberta, providing patients with access to medical cannabis and related healthcare services. Invictus aims to capitalize on the expanding cannabis market in Canada by integrating various aspects of the industry, from cultivation to retail and healthcare services. However, the company faces competition from other established and emerging players in the cannabis sector. The company's strategy involves strategic investments and acquisitions to strengthen its market position and expand its product offerings. Invictus MD Strategies Corp. navigates the evolving regulatory landscape of the cannabis industry in Canada, adapting its operations to comply with changing laws and regulations.
What Products and Services Does IVITF Offer?
- Invests in synergistic businesses within the cannabis industry in Canada.
- Produces and sells medical cannabis.
- Sells plant fertilizers and nutrients for hydroponics.
- Provides other supplies for hydroponics.
- Operates medical clinics in Alberta.
- Acquires businesses in the cannabis sector.
- Develops businesses in the cannabis sector.
How Does IVITF Make Money?
- Generates revenue through the sale of medical cannabis.
- Generates revenue through the sale of fertilizers and hydroponics supplies.
- Generates revenue from the operation of medical clinics.
- Invests in and develops cannabis-related businesses, potentially generating returns through equity appreciation or dividends.
What Industry Does IVITF Operate In?
Invictus MD Strategies Corp. operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing legalization, growing consumer demand, and intense competition. Companies are vying for market share through product innovation, strategic partnerships, and expansion of distribution networks. The industry faces regulatory hurdles, including licensing requirements and restrictions on marketing and advertising. As a smaller player, Invictus MD Strategies Corp. competes with larger, more established companies with greater resources and brand recognition. Success in this industry requires efficient operations, strong branding, and the ability to adapt to changing regulations.
Who Are IVITF's Key Customers?
- Patients seeking medical cannabis for various conditions.
- Commercial cannabis growers using fertilizers and hydroponics supplies.
- Individual cannabis growers using fertilizers and hydroponics supplies.
- Businesses in the cannabis industry that Invictus invests in or acquires.
Company Profile
Invictus MD Strategies Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Daniel Stanislav Kriznic CA, CPA. IVITF has traded publicly since 2015.
F-Score 3/9Financial Health
Invictus MD Strategies Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.62 places it in the distress zone, a signal of elevated financial risk.
ROE -32%Key Financial Metrics
Return on equity for Invictus MD Strategies Corp. stands at -31.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.2%, showing how much profit it generates from its asset base. A current ratio of 3.05 indicates the company holds enough short-term assets to cover its near-term obligations.
IVITF Valuation & Market Position
With a $4.45M market cap, Invictus MD Strategies Corp. sits in the micro-cap segment of the market. Relative to its peer group, IVITF's quantitative score of 52/100 is below the peer average of 66/100.
FY2027 estForward Outlook
Wall Street analysts project Invictus MD Strategies Corp. revenue of about $9.4M for fiscal 2027, with EPS near $-0.18.
IVITF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified operations across cannabis production, retail, and healthcare.
- Established presence in the Canadian cannabis market.
- Synergistic business model integrating various aspects of the cannabis industry.
- Operation of medical clinics providing direct access to patients.
Bear Case
- Negative profit margin and gross margin indicating financial challenges.
- Limited financial resources compared to larger competitors.
- Reliance on the Canadian cannabis market, exposing it to regulatory risks.
- OTC listing introducing additional risks related to liquidity and regulatory oversight.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IVITF Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Aug 29, 2019
IVITF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IVITF.
Price Targets
Wall Street price target analysis for IVITF.
IVITF MoonshotScore
What does this score mean?
The MoonshotScore rates IVITF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Daniel Stanislav Kriznic CA, CPA
CEO
Daniel Stanislav Kriznic is a Chartered Accountant (CA) and Certified Public Accountant (CPA). His background likely includes extensive experience in financial management, accounting, and auditing. Given his credentials, he likely has a strong understanding of financial reporting, compliance, and risk management. His previous roles and experiences are not detailed in the provided information, but his qualifications suggest expertise in corporate finance and accounting principles. He is expected to bring financial acumen to the leadership of Invictus MD Strategies Corp.
Track Record: Specific achievements and strategic decisions under Daniel Stanislav Kriznic's leadership are not detailed in the provided information. Therefore, it is not possible to assess his track record or identify key milestones achieved during his tenure. His impact on the company's performance and strategic direction remains unknown based on the available data.
IVITF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Invictus MD Strategies Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, lower trading volume, and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and increased volatility. These companies may not be current in their reporting requirements.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume on the OTC market.
- Lack of regulatory oversight compared to major exchanges.
- Potential for information asymmetry due to limited disclosure requirements.
- Increased price volatility due to speculative trading and limited institutional interest.
- Risk of delisting or trading suspension due to non-compliance with OTC market rules.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their experience in the cannabis industry.
- Evaluate the company's business model and competitive positioning.
- Analyze the company's capital structure and debt levels.
- Review the company's OTC Markets profile and disclosure filings.
- Check for any regulatory actions or legal proceedings involving the company.
- Monitor the company's trading volume and price volatility.
- Operation of medical clinics in Alberta indicates a tangible business activity.
- Involvement in the production and sale of medical cannabis suggests a focus on a regulated market.
- Investment in synergistic businesses within the cannabis industry demonstrates a strategic approach.
- CEO with CA and CPA credentials suggests financial expertise within the leadership team.
IVITF Healthcare Stock FAQ
What does Invictus MD Strategies Corp. do?
Invictus MD Strategies Corp. operates within the Canadian cannabis industry, focusing on the production, distribution, and sale of medical cannabis. Additionally, the company invests in synergistic businesses within the cannabis sector, including the production and sale of fertilizers and hydroponics supplies. Invictus also operates medical clinics in Alberta, providing patients with access to medical cannabis and related healthcare services. The company aims to capitalize on the growing demand for cannabis products and services in Canada through its diversified operations.
What do analysts say about IVITF stock?
There is currently no available analyst coverage or consensus on IVITF stock. Given its OTC listing and micro-cap status, the company may not attract significant attention from institutional analysts. Investors should conduct their own due diligence and consider the company's financial performance, competitive landscape, and the risks associated with OTC-listed companies before making any investment decisions. The lack of analyst coverage underscores the speculative nature of this investment.
What are the main risks for IVITF?
The main risks for Invictus MD Strategies Corp. include intense competition in the Canadian cannabis market, evolving regulatory landscape, fluctuations in cannabis prices, limited access to capital, and negative profit and gross margins. As an OTC-listed company, IVITF faces additional risks related to liquidity, regulatory oversight, and information asymmetry. The company's financial performance raises concerns about its ability to sustain operations and achieve profitability. Investors should carefully consider these risks before investing in IVITF.
What are the key factors to evaluate for IVITF?
Invictus MD Strategies Corp. (IVITF) holds an AI score of 52/100 (moderate). Not financial advice.
How frequently does IVITF data refresh on this page?
IVITF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IVITF's recent stock price performance?
Invictus MD Strategies Corp. (IVITF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified operations across cannabis production, retail, and healthcare. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IVITF overvalued or undervalued right now?
Valuing Invictus MD Strategies Corp. (IVITF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IVITF?
Before investing in Invictus MD Strategies Corp. (IVITF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for comprehensive analysis.
- OTC listing introduces additional risks and uncertainties.
- Lack of analyst coverage limits independent assessment.